Recent breast cancer studies (19,20) reported that high expression of cyclooygenase-2 (Cox-2), encoded by PTGS2, is associated with poor survival in ERα-negative breast cancer patients, when compared to ERα-positive breast cancers. This evidence concerns the gene PTGS2 and breast carcinoma.